Home
/
INTERPACE BIOSCIENCES, INC.
/
Financials
/
Quarterly
INTERPACE BIOSCIENCES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that INTERPACE BIOSCIENCES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2022
$1.27M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$1.96M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$2.45M
May 12, 2023
Q3
2018
Sep 30, 2018
$16.06M
Nov 14, 2018
Q2
2018
Jun 30, 2018
$10.31M
Aug 9, 2018
Q3
2015
Sep 30, 2015
$36.63M
Nov 12, 2015
Q2
2015
Jun 30, 2015
$36.34M
Aug 14, 2015
Q1
2015
Mar 31, 2015
$38.32M
May 12, 2015
Q3
2015
Sep 30, 2014
$28.26M
Nov 12, 2015
Q2
2015
Jun 30, 2014
$31.01M
Aug 14, 2015
Q1
2015
Mar 31, 2014
$31.83M
May 12, 2015
Q3
2014
Sep 30, 2013
$34.26M
Nov 5, 2014
Q2
2014
Jun 30, 2013
$37.25M
Aug 14, 2014
Q1
2014
Mar 31, 2013
$42.92M
Aug 19, 2014
Q3
2013
Sep 30, 2012
$31.78M
Sep 30, 2014
Q2
2013
Jun 30, 2012
$27.81M
Aug 5, 2013
Q1
2013
Mar 31, 2012
$31.68M
May 14, 2013
Q3
2012
Sep 30, 2011
$36.07M
Nov 6, 2012
Q2
2012
Jun 30, 2011
$38.64M
Aug 14, 2012
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.76M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$9.23M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$11.52M
May 8, 2025
Q3
2025
Sep 30, 2024
$12.30M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$12.04M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$10.18M
May 8, 2025
Q3
2024
Sep 30, 2023
$9.08M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$11.03M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$9.83M
May 9, 2024
Q3
2023
Sep 30, 2022
$8.19M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$7.40M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$7.92M
May 12, 2023
Q3
2022
Sep 30, 2021
$8.06M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$11.16M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$9.83M
May 16, 2022
Q3
2021
Sep 30, 2020
$8.25M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$5.45M
Aug 11, 2021
Q1
2021
Mar 31, 2020
$9.06M
May 11, 2021
Q3
2020
Sep 30, 2019
$7.73M
Jan 20, 2021
Q2
2020
Jun 30, 2019
$6.27M
Jan 19, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$4.81M
May 15, 2018
Q3
2017
Sep 30, 2017
$4.20M
Nov 13, 2017
Q2
2017
Jun 30, 2017
$3.86M
Aug 10, 2017
Q1
2018
Mar 31, 2017
$3.47M
May 15, 2018
Q3
2017
Sep 30, 2016
$3.32M
Nov 13, 2017
Q2
2017
Jun 30, 2016
$3.61M
Aug 10, 2017
Q1
2017
Mar 31, 2016
$3.04M
May 12, 2017
Q3
2016
Sep 30, 2015
$2.51M
Nov 17, 2016
Q2
2016
Jun 30, 2015
$2.25M
Aug 15, 2016
Q1
2016
Mar 31, 2015
$2.12M
May 12, 2016
Q3
2014
Sep 30, 2014
$29.25M
Nov 5, 2014
Q2
2014
Jun 30, 2014
$31.58M
Aug 14, 2014
Q1
2014
Mar 31, 2014
$32.78M
Aug 19, 2014
Q3
2014
Sep 30, 2013
$34.26M
Nov 5, 2014
Q2
2014
Jun 30, 2013
$37.25M
Aug 14, 2014
Q1
2014
Mar 31, 2013
$42.92M
Aug 19, 2014
Q3
2013
Sep 30, 2012
$31.78M
Sep 30, 2014
Q2
2013
Jun 30, 2012
$27.81M
Aug 5, 2013
Q1
2013
Mar 31, 2012
$31.68M
May 14, 2013
Q3
2012
Sep 30, 2011
$36.07M
Nov 6, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$911.0K
Nov 12, 2025
Q3
2025
Jun 30, 2025
($640.0K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($640.0K)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.65M
May 8, 2025
Q2
2025
Mar 31, 2025
$1.65M
Aug 7, 2025
Q3
2025
Mar 31, 2025
$1.65M
Nov 12, 2025
Q3
2025
Sep 30, 2024
$1.68M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$2.44M
Aug 7, 2025
Q3
2025
Jun 30, 2024
$2.44M
Nov 12, 2025
Q1
2025
Mar 31, 2024
$708.0K
May 8, 2025
Q3
2025
Mar 31, 2024
$708.0K
Nov 12, 2025
Q2
2025
Mar 31, 2024
$708.0K
Aug 7, 2025
Q3
2024
Sep 30, 2023
($614.0K)
Nov 8, 2024
Q3
2024
Jun 30, 2023
$175.0K
Nov 8, 2024
Q2
2024
Jun 30, 2023
$175.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$351.0K
May 9, 2024
Q3
2024
Mar 31, 2023
$351.0K
Nov 8, 2024
Q2
2024
Mar 31, 2023
$351.0K
Aug 8, 2024
Q3
2023
Sep 30, 2022
($14.21M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($3.94M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.15M
Nov 12, 2025
Q2
2025
Jun 30, 2025
($468.0K)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.83M
May 8, 2025
Q3
2025
Sep 30, 2024
$2.30M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$2.63M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$1.11M
May 8, 2025
Q3
2024
Sep 30, 2023
($16.0K)
Nov 8, 2024
Q2
2024
Jun 30, 2023
$832.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$675.0K
May 9, 2024
Q3
2023
Sep 30, 2022
($780.0K)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($1.91M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($977.0K)
May 12, 2023
Q3
2022
Sep 30, 2021
($1.83M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($2.91M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($3.82M)
May 16, 2022
Q3
2021
Sep 30, 2020
($6.01M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($5.77M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($6.35M)
May 11, 2021
Q3
2020
Sep 30, 2019
($7.13M)
Jan 20, 2021
Q2
2020
Jun 30, 2019
($5.35M)
Jan 19, 2021